BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10321933)

  • 1. Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.
    Hosking DJ
    Bone; 1999 May; 24(5 Suppl):69S-71S. PubMed ID: 10321933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of risedronate in Paget's disease.
    Miller PD
    Bone; 1999 May; 24(5 Suppl):91S-92S. PubMed ID: 10321937
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphosphonates in Paget's disease.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG
    Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract]   [Full Text] [Related]  

  • 4. Ibandronate treatment in Paget's disease of bone.
    Grauer A; Heichel S; Knaus J; Dosch E; Ziegler R
    Bone; 1999 May; 24(5 Suppl):87S-89S. PubMed ID: 10321936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Paget's disease and its therapeutic management].
    Orcel P; Rousière M
    Presse Med; 2005 Apr; 34(8):612-6. PubMed ID: 15962504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
    Kanis JA; Preston CJ; Beard DJ; Beneton M; Harris S; Russell RG
    Bone; 1985; 6(2):69-72. PubMed ID: 2409999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paget's disease and bisphosphonates.
    Rendina D; De Filippo G; Mossetti G
    N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
    Miller PD; Brown JP; Siris ES; Hoseyni MS; Axelrod DW; Bekker PJ
    Am J Med; 1999 May; 106(5):513-20. PubMed ID: 10335722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in the deformity of the face in Paget's disease treated with diphosphonates.
    Bickerstaff DR; Douglas DL; Burke PH; O'Doherty DP; Kanis JA
    J Bone Joint Surg Br; 1990 Jan; 72(1):132-6. PubMed ID: 2137127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.
    Drake WM; Kendler DL; Brown JP
    Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
    N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.
    Buckler H; Fraser W; Hosking D; Ryan W; Maricic MJ; Singer F; Davie M; Fogelman I; Birbara CA; Moses AM; Lyles K; Selby P; Richardson P; Seaman J; Zelenakas K; Siris E
    Bone; 1999 May; 24(5 Suppl):81S-85S. PubMed ID: 10321935
    [No Abstract]   [Full Text] [Related]  

  • 14. Paget's disease of bone.
    Haddad JG
    Curr Ther Endocrinol Metab; 1994; 5():525-7. PubMed ID: 7704787
    [No Abstract]   [Full Text] [Related]  

  • 15. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronate treatment in active Paget's disease.
    Chung G; Keen RW
    Ann Rheum Dis; 2003 Mar; 62(3):275-6. PubMed ID: 12594123
    [No Abstract]   [Full Text] [Related]  

  • 17. Two cases of monostotic Paget's disease: effects of bisphosphonate.
    Hoshiro M; Harada T; Iwai H; Miyatake T; Nishimura A; Ohno Y; Aoki N
    Endocr J; 2003 Aug; 50(4):385-92. PubMed ID: 14599111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects and therapy of Paget's disease (osteitis deformans)].
    Ringe JD
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1207-12. PubMed ID: 6223799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.